4//SEC Filing
Davis Andrew 4
Accession 0001209191-23-056446
CIK 0001446847other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:05 PM ET
Size
5.2 KB
Accession
0001209191-23-056446
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Sale
Class A Common Stock
2023-11-20$9.69/sh−3,287$31,851→ 217,374 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The reporting person acquired 1,334 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2023.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001932525
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:05 PM ET
- Size
- 5.2 KB